LncRNAs like MALAT1 and NEAT1 contribute to radioresistance, with MALAT1 modulating resistance in nasopharyngeal cancer via miR-1 inactivation and NEAT1 promoting resistance through the miR-204/ZEB1 axis [44,45]. The gene discussed is NEAT1; the disease is nasopharyngeal carcinoma.